Related Experiment Video
Updated: Feb 12, 2026

Using High Content Imaging to Quantify Target Engagement in Adherent Cells
Published on: November 29, 2018
A high content, high throughput cellular thermal stability assay for measuring drug-target engagement in living cells
1Vernalis Research, Granta Park, Cambridge, United Kingdom.
Abstract:
Determining and understanding drug target engagement is critical for drug discovery. This can be challenging within living cells as selective readouts are often unavailable. Here we describe a novel method for measuring target engagement in living cells based on the principle of altered protein thermal stabilization / destabilization in response to ligand binding. This assay (HCIF-CETSA) utilizes high content, high throughput single cell immunofluorescent detection to determine target protein levels following heating of adherent cells in a 96 well plate format. We have used target engagement of Chk1 by potent small molecule inhibitors to validate the assay. Target engagement measured by this method was subsequently compared to target engagement measured by two alternative methods (autophosphorylation and CETSA). The HCIF-CETSA method appeared robust and a good correlation in target engagement measured by this method and CETSA for the selective Chk1 inhibitor V158411 was observed. However, these EC50 values were 23- and 12-fold greater than the autophosphorylation IC50. The described method is therefore a valuable advance in the CETSA method allowing the high throughput determination of target engagement in adherent cells.
Insights
A new assay, high content imaging-based cellular thermal shift assay (HCIF-CETSA), measures drug target engagement in living cells. This method offers a robust, high-throughput approach for drug discovery research.
Area of Science:
- Biochemistry
- Pharmacology
- Cell Biology
Background:
- Drug target engagement is crucial for drug discovery but challenging to measure in living cells.
- Existing methods often lack selectivity or high-throughput capabilities.
Purpose of the Study:
- To develop and validate a novel, high-throughput method for measuring drug target engagement in living cells.
- To assess the utility of the assay for drug discovery applications.
Main Methods:
- Developed the high content imaging-based cellular thermal shift assay (HCIF-CETSA).
- Utilized immunofluorescent detection of target protein levels after thermal treatment of adherent cells in a 96-well plate format.
- Validated the assay using Chk1 target engagement by small molecule inhibitors.
Main Results:
- HCIF-CETSA demonstrated robustness and correlated well with traditional CETSA for a selective Chk1 inhibitor.
- The assay provides a valuable advancement for high-throughput target engagement determination in adherent cells.
- Observed differences in EC50 values compared to autophosphorylation IC50 highlight assay-specific characteristics.
Conclusions:
- HCIF-CETSA is a valuable new method for measuring drug target engagement in living cells.
- The assay facilitates high-throughput screening and drug discovery efforts.
- This technique enhances the ability to assess target engagement in a cellular context.
Related Concept Videos
Drugs that Stabilize Microtubules
Drug Product Stability
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Measurement of Air Content in Concrete
The pressure method,...
Cellular Membranes and Drug Transport
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
RNA Stability

